METHYLPHENIDATE HYDROCHLORIDE
METHYLPHENIDATE HYDROCHLORIDE
Approval overview METHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 211796 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPHENIDATE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG Sponsor GRANULES Submission history Latest submission status date: 2024-12-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 211796 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPHENIDATE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG Sponsor GRANULES Submission history Latest submission status date: 2024-12-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.